
|Articles|October 15, 2009
- October 2009
- Volume 75
- Issue 10
DIABETES PRODUCTS
Advertisement
Articles in this issue
over 16 years ago
Case Studiesover 16 years ago
Health Systems Product Newsover 16 years ago
Women's Health Watchover 16 years ago
Rx Product News Profile: A closer look at new FDA actions: Multaqover 16 years ago
Cholesterol Watchover 16 years ago
Biosimilars and Health Care Reformover 16 years ago
Gestational Diabetes: What Patients Need to Knowover 16 years ago
Blood Glucose Monitors for the Pediatric Populationover 16 years ago
2-Minute Consultation: Preventive Foot Care for Diabetes Patientsover 16 years ago
GERD WatchAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Factors Associated With GLP-1 RA Nonresponse in T2D—and What Pharmacists Should Screen For
2
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
3
ADA 2026: Optimized Inhaled Insulin Dosing Outperforms Subcutaneous Analogs for Postprandial Glucose in T1D
4
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
5






































































































































